Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1

Por Zhao, Dan, Amria, Shereen, Hossain, Azim, Sundaram, Kumaran, Komlosi, Peter, Nagarkatti, Mitzi, Haque, Azizul
Publicado em 2011

Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma

Por Goldstein, Oliver G., Hajiaghamohseni, Laela M., Amria, Shereen, Sundaram, Kumaran, Reddy, Sakamuri V., Haque, Azizul
Publicado em 2008

Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47 000 MW acid labile protein in CD4(+) T-cell recognition

Por God, Jason M, Zhao, Dan, Cameron, Christine A, Amria, Shereen, Bethard, Jennifer R, Haque, Azizul
Publicado em 2014

HLA Class II Defects in Burkitt Lymphoma: Bryostatin-1-Induced 17 kDa Protein Restores CD4+ T-Cell Recognition

Por Hossain, Azim, God, Jason M., Radwan, Faisal F. Y., Amria, Shereen, Zhao, Dan, Bethard, Jennifer R., Haque, Azizul
Publicado em 2011

Elevation of c-MYC Disrupts HLA Class II-mediated Immune Recognition of Human B-cell Tumors()

Por God, Jason M., Cameron, Christine, Figueroa, Janette, Amria, Shereen, Hossain, Azim, Kempkes, Bettina, Bornkamm, Georg W., Stuart, Robert K., Blum, Janice S., Haque, Azizul
Publicado no J Immunol (2015)